Acrux Limited ARUXF
ARUXF
Acrux Limited PKTX
ProtoKinetix, Incorporated AXIM
AXIM Biotechnologies, Inc. ZLDAF
Zelira Therapeutics Limited HAVLF
HAVN Life Sciences Inc. SIGY
Sigyn Therapeutics, Inc. REPCF
RepliCel Life Sciences Inc. IBOGF
Universal Ibogaine Inc. RNUGF
ReNeuron Group plc AGNPF
Algernon Pharmaceuticals Inc.
Acrux Limited PKTX
ProtoKinetix, Incorporated AXIM
AXIM Biotechnologies, Inc. ZLDAF
Zelira Therapeutics Limited HAVLF
HAVN Life Sciences Inc. SIGY
Sigyn Therapeutics, Inc. REPCF
RepliCel Life Sciences Inc. IBOGF
Universal Ibogaine Inc. RNUGF
ReNeuron Group plc AGNPF
Algernon Pharmaceuticals Inc.
Performance
| Periode | ARUXF | PKTX | AXIM | ZLDAF | HAVLF | SIGY | REPCF | IBOGF | RNUGF | AGNPF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -75.00 % | -23.86 % | 123.66 % | -16.39 % | 280.00 % | -37.82 % | -95.00 % | -63.41 % | 0.00 % | 21.96 % |
| YTD | -66.67 % | -32.73 % | 646.32 % | -39.05 % | 90.00 % | -45.71 % | -90.00 % | -46.43 % | 0.00 % | 34.34 % |
| 1Y | -66.67 % | -32.32 % | 780.75 % | -36.91 % | -63.46 % | -45.71 % | -90.00 % | -46.43 % | 0.00 % | 41.49 % |
| 3Y | -83.33 % | -79.70 % | -50.93 % | -65.41 % | -95.00 % | 584.00 % | -98.05 % | -59.46 % | -98.90 % | -85.28 % |
| 5Y | -92.86 % | -92.95 % | -97.11 % | -98.15 % | -99.99 % | 17.93 % | -99.41 % | -92.07 % | -99.89 % | -98.43 % |
| 10Y | -98.00 % | -90.43 % | -97.64 % | -96.67 % | -99.99 % | 17.93 % | -99.95 % | -92.07 % | -99.96 % | -99.64 % |
| From the beginning | -99.35 % | -98.40 % | -99.86 % | -96.67 % | -99.99 % | 17.93 % | -99.94 % | -92.07 % | -100.00 % | -99.64 % |